Kuala lumpur: Recently, Professor An Chiying and her medical team at Shenzhen Hengsheng Hospital, China, announced a groundbreaking achievement: since June 2024, they have successfully helped 24 patients with Type 1 diabetes mellitus (T1DM) discontinue insulin therapy through holistic integrative medicine (HIM)-an optimized combination of traditional Chinese and Western medicine-thereby achieving a functional cure. The longest duration of insulin discontinuation has reached 14 months. This breakthrough offers new hope for global T1DM treatment and marks a remarkable advance in integrated Chinese and Western medicine for autoimmune diseases.

According to BERNAMA News Agency, the innovative approach adopted by Professor An and her team involves a carefully balanced regimen that integrates the principles of traditional Chinese medicine with modern Western medical practices. This method has shown a significant positive impact on the patients' ability to regulate their blood sugar levels without the need for insulin injections.

The success of this treatment in enabling patients to maintain stable blood sugar levels over such an extended period is unprecedented. The medical team's work is particularly notable given the challenges associated with managing T1DM, a condition where the body's immune system attacks insulin-producing cells in the pancreas.

The implications of this development are substantial, not only for patients in China but potentially for millions of T1DM sufferers worldwide. The findings from Shenzhen Hengsheng Hospital could pave the way for new treatment protocols and significantly alter the landscape of diabetes care.

As the medical community continues to analyze these results, there is cautious optimism about the potential for holistic integrative medicine to serve as a viable treatment option for T1DM. Further research and clinical trials will be essential to validate these findings and explore their applicability on a larger scale.